Trial intelligence / Profile preview

MucPreDex: Prevention of radiation-induced oral mucositis using dexpanthenol mouth rinse

2023-510522-32-00Phase 3Authorised

Sponsor
University of Bonn
Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexpanthenol in stomatitis, sponsored by University of Bonn. Primary endpoint: Primary oral mucositis grade. Planned start Oct 2024; status: authorised.

02

Drugs

dexpanthenol
03

Conditions

stomatitis

Beyond the preview

Go deeper on 2023-510522-32-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-510522-32-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call